Second, aCL status at the time of active neuropsychiatric manifestations was not available in this SLE patient cohort with past neuropsychiatric symptoms, which precludes evaluation of our results in the light of fluctuation in aCL levels [19]. The gene discussed is ACLY; the disease is systemic lupus erythematosus.